March 16, 2021 – Imagin Medical Reports Manufacturing Progress
February 18, 2021 – Imagin Medical Closes Second Tranche of Convertible Note Offering
January 13, 2021 – Imagin Medical Builds Momentum for 2021
November 10, 2020 – Imagin Medical Closes First Tranche of Convertible Notes Offering
October 22, 2020 – Imagin Medical Announces Agenda for KOL Virtual Investor Event on October 29, 2020
October 22, 2020 – Imagin Medical Announces Proposed Offering of $3 Million of Convertible Notes and Share Consolidation
October 7, 2020 – Imagin Medical Selects Lighthouse Imaging as i/Blue Imaging System Contract Manufacturer
September 29, 2020 – Imagin Medical to Host KOL Webcast Event on October 29, 2020
August 28, 2020 – Imagin Medical Reports Fiscal 2020 Third Quarter Results
July 15, 2020 – Imagin Medical To Begin Testing of i/Blue Imaging System on Anatomical Bladder Models
May 28, 2020 – Imagin Medical Imagin Medical Reports Fiscal 2020 Second Quarter Results
May 21, 2020 – Imagin Medical To Report Second Fiscal Quarter 2020 Financial Results on May 28, 2020 – Conference Call
May 21, 2020 – Imagin Medical Announces Successful Delivery of Functional i/Blue Imaging System
May 14, 2020 – Imagin Medical Reports Response to Covid-19
May 12, 2020 – Imagin Medical Supports Cancer Awareness Month
April 9, 2020 – Imagin Medical Receives Approval to Reprice and Extend Term of Warrants
February 10, 2020 – Imagin Medical Reports Physician Feedback on i/Blue Imaging System for Bladder Cancer Visualization
February 27, 2020 – Imagin Medical Reports Fiscal 2020 First Quarter Results
February 20, 2020 – Imagin Medical to Report First Fiscal Quarter 2020 Financial Results on February 27, 2019 – Conference Call to Follow
February 10, 2020 – Imagin Medical to Present at NobleCon16
January 23, 2020 – Imagin Medical Finishes 2019 Strong and Provides Insight into 2020 and Beyond
January 21, 2020 – Imagin Medical Closes Oversubscribed Private Placement
January 10, 2020 – Imagin Medical Announces Stock Option Grant
January 8, 2020 – Imagin Medical Reports Successful Completion of Design Verification and Announces Private Placement
December 24, 2019 – Imagin Medical Reports Fiscal Year End 2019 Results
December 18, 2019 – Imagin Medical Announces Results of Annual Meeting of Shareholders
December 3, 2019 – Imagin Medical to Present at the First Annual BIOTuesdays Pre-JPM Virtual Conference
November 12, 2019 – Imagin Medical Confirms Functional Units on Schedule for Products Design Verification
October 17, 2019 – Imagin Medical Announces Social Media Campaign Launch
September 26, 2019 – Imagin Medical Announces Meeting Regarding i/Blues’s Regulatory Pathway
August 27, 2019 – Imagin Medical Reports Fiscal 2019 Third Quarter Results
July 15, 2019 – Imagin Medical Progress Update
June 24, 2019 – Imagin Medical Announces Stock Option Grant
June 11, 2019 – Imagin Medical Reports Fiscal 2019 Second Quarter Financial Results
June 6, 2019 – Imagin Medical to Report Fiscal 2019 Second Quarter Results on June 11, 2019 – Conference Call to Follow
April 17, 2019 – Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish Kamat to Its Scientific Board of Advisors
April 2, 2019 – Imagin Medical Completes Assembly of i/Blue Imaging Functional Unit
February 27, 2019 – Imagin Medical Reports Fiscal Q1 2019 Results
February 19, 2019 – Imagin Medical to Report Fiscal Q1 2019 Results on February 27, 2019 – Conference Call to Follow
January 23, 2019 – Imagin Medical to Present at Noble Capital Markets 15th Annual Investor Conference
January 9, 2019 – Imagin Medical Posts New Presentation on Its Website
December 20, 2018 – Imagin Medical Reports Fiscal Year End 2018 Results
December 18, 2018 – Imagin Medical Announces Results of Annual Meeting of Shareholders
November 28, 2018 – Imagin Medical Comments on Recent Promotional Activity Pursuant to OTC Markets Request
October 31, 2018 – Imagin Medical Receives Approximately $1 from Exercise of Warrants
October 2, 2018 – Imagin Medical Announces Changes to its Board of Directors
August 14, 2018 – Imagin Medical Reports Fiscal 2018 Third Quarter Results
July 25, 2018 – Imagin Medical Announces Stock Options Granted
July 17, 2018 – Imagin Medical Reports Research Study Progress
June 27, 2018 – Imagin Medical Announces Uplisting to OTCQB
June 22, 2018 – Imagin Medical Provides Further Details on Kilmer Lucas Engagement
June 21, 2018 – Imagin Engages Kilmer Lucas for Cross-border Investor Relations
April 26, 2018 – Imagin Gains Momentum; Positive Progress in Research Study
April 19, 2018 – IME Closes Oversubscribed Private Placement
April 12, 2018 – Imagin Medical Closing Private Placement
April 3, 2018 – Imagin Medical Announces Private Placement
March 8, 2018 – Imagin Medical Closes Private Placement
March 7, 2018 – Imagin Medical Product Re-Design on Schedule
March 1, 2018 – Imagin Medical Announces Private Placement
February 26, 2018 – Imagin Medical Appoints Director of Regulatory Affairs
February 15, 2018 – Imagin Medical Closes Private Placement
February 9, 2018 – American Urological Association (AUA) Honors Imagin Medical Scientific Advisor
February 7, 2018 – University of Rochester Initial Research Study Patients Completed
January 30, 2018 – Imagin Medical Announces Private Placement
January 30, 2018 – John Vacha Joins Imagin Medical Board of Directors
January 22, 2018 – Imagin Medical Research Study Begins
January 17, 2018 – Imagin Medical Stock Options Granted
January 15, 2018 – Imagin Medical Recruits Senior Healthcare CFO
January 9, 2018 – Imagin Medical Builds Momentum for 2018
January 9, 2018 – Imagin Medical Stock Option Granted
December 14, 2017 – Imagin Medical Stock Options Granted
December 8, 2017 – Imagin Medical Investors Exercise Warrants Generating $1M
November 29, 2017 – Imagin Medical Opens Enrollment for Research Study
November 28, 2017 – Imagin Medical Stock Options Granted
November 9, 2017 – Prototype Redesign
November 6, 2017 – Enhanced Cystoscopy Improves Bladder Cancer Detection
October 27, 2017 – Imagin Medical Scientific Advisor Attends Society of International Urology Meeting
October 26, 2017 – Imagin Medical Announces Stock Options Granted
October 26, 2017 – Imagin Medical Announces PP for Communications
October 19, 2017 – Imagin Medical Announces Clinical Research Criteria
October 18, 2017 – Imagin Medical Closed $1M Private Placement
October 13, 2017 – Imagin Medical Closing 2nd and Final Tranche of $1M Private Placement
October 11, 2017 – Urologists Invest in Imagin Medical Private Placement
October 5, 2017 – Clinical Research Study Listed on Government Website
October 4, 2017 – Imagin Medical Closing Tranche 1 and Increasing Private Placement Offering
September 27, 2017 – Imagin Medical Receives 1st In-Human Research Study Approval
September 26, 2017 – Imagin Medical Announces Private Placement
June 28, 2017 – 2017 Mid Year Update
April 10, 2017 – New Release – Imagin Medical Grants Stock Options
March 3, 2017 – New Release – Imagin Medical Closes Private Placement of Convertible Notes
March 2, 2017 – New Release – Imagin Medical Final Product Design on Track
February 24, 2017 – Imagin Medical Arranges Private Placement of Convertible Notes
February 22, 2017 – New Release – Imagin Medical Signs $8M Term Sheet with New York Private Equity Firm Alumina Partners LLC
February 9, 2017 – New Release – Imagin Medical Technology Presented at Photonics West 2017
January 10, 2017 – New Release – Imagin Medical Poised for 2017 Success
December 9, 2016 – News Release – Imagin Medical Closes Tranche 2 of Private Placement
December 8, 2016 – News Release – Imagin Medical Chooses Optel, Inc. to Design i/Blue Prototype for Commercialization
December 1, 2016 – News Release – Imagin Medical Completes Alpha B Prototype
November 10, 2016 – News Release – Dr. Roger Buckley Joins Imagin Medical’s Scientific Board of Advisors
October 27, 2016 – News Release – Dr. Liam J. Hurley Joins Imagin Medical’s Scientific Board of Advisors
October 20, 2016 – News Release – Imagin Medical Closes Tranche 1 of Private Placement for $385,000
October 6, 2016 – News Release – Imagin Medical’s Quality Management System Initial Phase Complete
September 29, 2016 – News Release – Ken Daignault Joins Imagin Medical’s Board of Directors
September 22, 2016 – News Release – Dr. Edward Messing, Chief of Urology, U Rochester Medical Center Joins Imagin Medical’s Scientific Board of Advisors
September 15, 2016 – News Release – Disruptive Technology Update
September 13, 2016 – News Release – Imagin Medical Issues Private Placement
August 1, 2016 – News Release – American Urological Association’s New Guidelines for Bladder Cancer Support Imagin Medical’s Objective
July 20, 2016 – News Release – Alpha Prototype on Schedule
June 9, 2016 – News Release – Imagin Signs Agreements to Support i/Blue Development: University of Rochester Laboratory of Laser Energetics and U.S. Department of Energy
May 24, 2016 – News Release – Imagin Attended American Urological Association Annual Meeting
May 10, 2016 – News Release – Imagin Medical Now Trading on Frankfurt and Stuttgart Exchanges
May 5, 2016 – News Release – Imagin Medical Attends America Urology Association Annual Meeting
April 28, 2016 – News Release – Imagin Medical Begins Trading on OTC
April 24, 2016 – News Release – Imagin Announces Dr. Ralph deVere White Named Chairman of the Scientific Advisory Board
February 23, 2016 – News Release – Imagin Medical Starts Trading On the CSE
February 9, 2016 – News Release – Acquisition Closing
December 10, 2015 – News Release – AGM results
November 18, 2015 – 2015 – News Release – Update on Transaction with BSS
October 5, 2015 – 2015 News Release re Definitive Agreement with BSS
July 9, 2015 – 2015 – News Release – LOI with BSS
